Skip to content
DNDi Logo
  • DNDi JAPAN
  • DNDi LATIN AMERICA
  • DNDi NORTH AMERICA
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Menu
  • ABOUT US
        • ABOUT US
        • BUSINESS MODEL
        • DNDi‘s POLICIES
        • DNDi WORLDWIDE
        • OUR PEOPLE
        • ANNUAL REPORTS
        • E-NEWS
        • JOB OPPORTUNITIES
        • CONTACT US
    • Close
  • DISEASES & PROJECTS
        • DISEASES
        • SLEEPING SICKNESS
        • LEISHMANIASIS
        • CHAGAS DISEASE
        • PAEDIATRIC HIV
        • FILARIAL DISEASE
        • MYCETOMA
        • HEPATITIS C
        • MALARIA
        • PROJECT PORTFOLIO
        • GLOBAL ANTIBIOTIC R&D PARTNERSHIP (GARDP)
        • TARGET PRODUCT PROFILES
        • CLINICAL TRIALS
        • OPEN INNOVATION PORTAL
    • Close
  • ACHIEVEMENTS
      • DNDi ACHIEVEMENTS
      • ASAQ
        Malaria
      • ASMQ
        Malaria
      • NECT
        Sleeping sickness
      • SSG&PM
        Visceral leishmaniasis
      • PAEDIATRIC BENZNIDAZOLE
        Chagas
      • NEW VL TREATMENTS – ASIA
        Visceral leishmaniasis
      • SUPERBOOSTER THERAPY
        Paediatric HIV/TB
      • FEXINIDAZOLE
        Sleeping sickness
    • Close
  • STRENGTHENING CAPACITY
        • OVERVIEW
        • TECHNOLOGY TRANSFERS
        • CHAGAS PLATFORM
        • HAT PLATFORM
        • LEAP PLATFORM
        • REDELEISH NETWORK
    • Close
  • ADVOCACY
      • ADVOCACY UPDATES
      • ACCESS
      • INTELLECTUAL PROPERTY
    • Close
  • MEDIA CENTRE
        • OVERVIEW
        • NEWS, VIEWS & STORIES
        • PRESS RELEASES
        • PRESS KIT
        • IN THE MEDIA
        • OUR PUBLICATIONS
        • E-NEWS
        • VIDEOS
        • SCIENTIFIC ARTICLES
        • EVENTS
    • Close
  • PARTNERS
      • OVERVIEW
      • BUSINESS MODEL
      • PARTNERS
      • BECOME A DNDi PARTNER
      • RFP
    • Close
  • DONATE
      • DONATE
      • HOW TO HELP
      • DONORS
      • KEY FINANCIAL FIGURES
    • Close
    • Close
  • Home
  • RFP

RFP

International courier services to support the conduct of a phase 3 clinical trial in uncomplicated gonorrhoea and neonatal/paediatric programmes

[Published: 26 November 2018]

GARDP is currently sourcing a global courier offering clinical samples shipment services to its programmes

    • Request for Proposal
    • Annex 1: Intent to Participate Letter
    • Annex 2: Q&A Form
RFP

Post navigation

Previous
Clinical trial supply services for phase III trial in uncomplicated gonorrhea
Next
DNDi website redesign

Partnership

  • Overview
  • Business Model
  • Partners
  • Become a DNDi Partner
  • RFP

Recent Articles

  • DNDi website redesign
  • International courier services to support the conduct of a phase 3 clinical trial in uncomplicated gonorrhoea and neonatal/paediatric programmes
  • Clinical trial supply services for phase III trial in uncomplicated gonorrhea

About DNDi

Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected patients.

Learn More

  • Vision & Mission
  • Business Plan
  • DNDi‘s Model
  • Diseases & Projects
  • Portfolio
  • Treatments
  • Clinical Trials
  • Annual Report
  • Scientific Articles
  • Contact Us

Work with Us

  • Donate
  • Partnership
  • RFP
  • Jobs

DNDi Worldwide

  • DNDi regional offices
  • DNDi Japan のサイトへはこちらから.
  • DNDi Latin America website
  • DNDi North America website
  • GARDP

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
  • Events

Newsletter

Sign up for the E-news newsletter! By subscribing, you agree that all info submitted will be processed according to our Privacy Policy. You can unsubscribe any time.

I want to receive

  • PRIVACY POLICY
  • TERMS OF USE
  • ACCEPTABLE USE POLICY
  • COOKIE POLICY
  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License
We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser. Read Cookie Policy. Close